177 related articles for article (PubMed ID: 17616481)
21. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
[TBL] [Abstract][Full Text] [Related]
22. The search for a tuberculosis vaccine: an elusive quest?
Nagelkerke NJ; de Vlas SJ; Mahendradhata Y; Ottenhoff TH; Borgdorff M
Tuberculosis (Edinb); 2006 Jan; 86(1):41-6. PubMed ID: 16253559
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic DNA vaccines against tuberculosis: a promising but arduous task.
Li JM; Zhu DY
Chin Med J (Engl); 2006 Jul; 119(13):1103-7. PubMed ID: 16834929
[TBL] [Abstract][Full Text] [Related]
24. [Therapeutic vaccines against tuberculosis: a glowing future].
Cardona PJ
Arch Bronconeumol; 2007 Nov; 43(11):591-3. PubMed ID: 17983541
[No Abstract] [Full Text] [Related]
25. Protection of mice against Mycobacterium tuberculosis infection by immunization with aqueous fraction of Triton X-100-soluble cell wall proteins.
Jeon BY; Kim HJ; Kim SC; Jo EK; Park JK; Paik TH; Kim SJ; Cho SN
Scand J Immunol; 2008 Jan; 67(1):18-23. PubMed ID: 18021187
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
27. Tuberculosis vaccines: time to reset the paradigm?
Lalvani A; Sridhar S; von Reyn CF
Thorax; 2013 Dec; 68(12):1092-4. PubMed ID: 23749816
[No Abstract] [Full Text] [Related]
28. MPT-51/CpG DNA vaccine protects mice against Mycobacterium tuberculosis.
Silva BD; da Silva EB; do Nascimento IP; Dos Reis MC; Kipnis A; Junqueira-Kipnis AP
Vaccine; 2009 Jul; 27(33):4402-7. PubMed ID: 19500525
[TBL] [Abstract][Full Text] [Related]
29. Progress and hindrances in tuberculosis vaccine development.
Doherty TM; Rook G
Lancet; 2006 Mar; 367(9514):947-9. PubMed ID: 16546547
[No Abstract] [Full Text] [Related]
30. Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis.
Hingley-Wilson SM; Sambandamurthy VK; Jacobs WR
Nat Immunol; 2003 Oct; 4(10):949-55. PubMed ID: 14515128
[TBL] [Abstract][Full Text] [Related]
31. TB vaccine development: where are we and why is it so difficult?
Wilkie ME; McShane H
Thorax; 2015 Mar; 70(3):299-301. PubMed ID: 25432943
[TBL] [Abstract][Full Text] [Related]
32. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
Dietrich J; Doherty TM
APMIS; 2009 May; 117(5-6):440-57. PubMed ID: 19400867
[TBL] [Abstract][Full Text] [Related]
33. Genomic study of Mycobacterium tuberculosis and its clinical applications.
Tyagi JS; Sharma D
Indian J Pediatr; 2002 Nov; 69 Suppl 1():S29-38. PubMed ID: 12501923
[TBL] [Abstract][Full Text] [Related]
34. Rational design of vaccines against tuberculosis directed by basic immunology.
Reece ST; Kaufmann SH
Int J Med Microbiol; 2008 Jan; 298(1-2):143-50. PubMed ID: 17702652
[TBL] [Abstract][Full Text] [Related]
35. TB vaccines: current status and future perspectives.
Aagaard C; Dietrich J; Doherty M; Andersen P
Immunol Cell Biol; 2009; 87(4):279-86. PubMed ID: 19350048
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.
Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH
Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445
[TBL] [Abstract][Full Text] [Related]
37. Tuberculosis vaccine research: the impact of immunology.
Barker LF; Brennan MJ; Rosenstein PK; Sadoff JC
Curr Opin Immunol; 2009 Jun; 21(3):331-8. PubMed ID: 19505813
[TBL] [Abstract][Full Text] [Related]
38. [Immunology of tuberculosis and current status of vaccine development].
Ulrichs T
Pneumologie; 2008 Mar; 62(3):143-7. PubMed ID: 18320494
[TBL] [Abstract][Full Text] [Related]
39. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
[TBL] [Abstract][Full Text] [Related]
40. Efficient tuberculosis treatment in mice using chemotherapy and immunotherapy with the combined DNA vaccine encoding Ag85B, MPT-64 and MPT-83.
Yu DH; Hu XD; Cai H
Gene Ther; 2008 May; 15(9):652-9. PubMed ID: 18288210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
